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Sunscreen preparations contall1l11g 5- meth:)xypsoralen at 
25 p.g/ ml and 50 p.g/ ml , and the appropriate vehicle only, 
Sunscreen only, and 5-methoxypsoralen only controls, were 
assessed for tumorigenic potential in hairless albino mice 
exposed to solar simulated radiation for a period of 44-46 
weeks. Some animals were observed for a 15 week post-
irradiation period. A wide range of statistical analyses has 
shown that, during the course of irradiation, the inclusion 
Sunlight is the major ca use of nonmelan oma skin ca ncer [1]. es peciall y in individuals w ith defective DN A repair, such as those wi th Xeroderma Pigmentosum [2) . Al-thou gh the w idely used sun screen para-aminobenzoic acid (PABA) enhan ces DNA th Yl11l11 e dlmer form atIon 
[3] and is a potential mutagen in the presence of ultraviolet ra-
dia tio n (UVR) [4]. anim al studies suggest that the risk of skin 
cancer in white skin could be reduced by protection from solar 
DVB radiation (290-315 nm) by the use of UVB sunscreen prep-
a r a tions, such as octyl dim ethyl PABA [5) . 
The main disadvantage of such a measure is that a sunscreen 
should be ca refully and repea tedl y applied. Use of effective sun-
screen preparations, however, may reduce the speed and intensity 
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Abbreviations: 
BHA: butylated hydroxy-anisol 
BHT: butylated hydroxy- toluene 
5-M 0 P: 5-methoxypsoralen 
PABA: para-aminobenzoic acid . 
S: sunscreens (PARSOL M CX plus ULTRACYD) 
SSR: solar simulated radiation 
TP A: 12-0-tetradecanoyl-phorbol-1 3-acetate 
UVB: 290-315 nm (terrestrial) 
UVR: ultrav iolet radiation 
of sunscreens eliminates the enhancem ent of phototumori-
genesis and malignancy that is normally observed with 5-
methoxypsoralen. There was, however, some indication 
of increased ri sk at the end of the postirradiation follow-
up period . Possible reasons for the protective effect of the 
sunscreens and the relevance of these data to the assessm ent 
of human ri sk are discussed. J iI/IIest D ennaro! 89:611-617, 
1987 
of a cosmetically appealing tan, which is usually the sole objecti ve 
of sunbathin g. The idea l solution to this problem would be the 
use of an agent that stimulates a rapid and protecti ve tan whil e 
presenting no additiona l risk to the user. At present, this idea l 
preparation is not known to exist, although it has been reported 
that DOPA-phosphate will stimulate pig mentation in the hairless 
pig mented m.ouse (Skh2) w ith and w itho ut UVB radiation [6). 
One approach that has been advoca ted is the use of sunscreen 
preparations that enhance pig mentation , such as those containing 
citrus oils, in particplar berga mot (Cilrtls bergalllia) oil, the ac tive 
melanogeni c ingredient of which is 5-methoxypsoralen (5-M O P). 
Such products, however, popular w ith a public intent o n being 
bronzed , have attracted much controversy [7-1 0) because 5-M OP 
is a mutagen [7) and a ca rcinogen in mice in the presence of UVR 
[11,12). Most studies of phototulllorigenesis in mice have been 
carried out with 5-I'yIOP at relatively high concentrations (100-300 
J.Lg/ ml) and witholjt the sunscreens present in cOlllmercial prep-
arations. In order to o btain a mo re realisti c es tim ate of human 
risk, it is important to ca rry out studies with the formulations 
used by the consumer. O ne such stud y has been done [1 3], but 
w ithout the w hicle plus irradiation contro ls that we believe to 
be essential fo r a valid evaluation of risk. We repo rt on photo-
tllmorigenesis studies, with sunscreen preparations containing 5-
MOP at 25 and 50 p.g/ ml and vehicle controls, in albino mice 
ex posed to solar simulated radiation (SSR). 
MATERIALS AND METH ODS 
T est preparations (i .e., those w ith 5-MOP and sunscreens) and 
appropriate control preparations were supplied by Laboratoires 
Goupil S.A. , Paris, France. The variolls preparati ons used are 
listed in Table L The vehicle was a mi xtu re of pea nut (Arachis 
hypogaea) oil and isopropyl m yristate with the antioxidants bu-
tylated hydroxy- al1isol (BHA) and butylated hydroxy-toluene 
(BHT) . Desired 5-MOP concentration in the test product is achieved 
by appropriate dilution of berga mot and other citrus oils in the 
vehicle. Preparations w ithout 5-MOP contain ed reconsti tuted 
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Table I. Stud y Pro toco ls and Purposes 
Study Treatment 
1 (with SSR) 5-M O P (50J.Lg/ ml ) w ith S 
5-M O P (50J.Lg/ml) 
without S 
Vehicle w ithout S 
2 (with SS R) 5-M O P (25J.Lg/ ml ) with S 
5-MO P (25J.Lg/ ml) 
without S 
Vehicle with S 
Vehicle without S 
2 (without SS R) No trea tment 
5-MO P (25 J.Lg/ ml ) with S 
5-MO P (25 J.Lg/m l) 
without S 
Vehicle without S 
Purpose 
Preliminary stud y to 
determine effects 
of sunscreens on 
5-M O P 
phototumorigenes is 
Full stud y to 
determine effect o f 
sunscreens o n 
5-MO P and vehicle 
photottumo rigenes is 
and tumor histology 
Dark controls to study 
effect o f 
5-M 0 P, sunscreens 
and vehicle on 
tumorigenesis 
Within each study the groups were treated concurrentl y. 
ssn., so lar simulated rad iat ion; S. Sllnsc reens. 
berga mot and citrus o ils. The quantitati ve fo rmulations are 
confidential. 
Presence or absence o f 5-M O P was verifi ed by TLC. Berga mot 
oil also contains o ther components; bergamottin, 5,7-dimethoxy-
oumarin and 7-methoxy-5-geranoxycoum arin were easil y iden-
tified by TLC in preparations containing 5-MOP [14] . Photo-
biologic acti vity was verified by g rowth inhibition in Candida 
albica lls [15 ,16] and was shown to be 5-M 0 P dose dependent. 
The preparations contained a mixture of tw o sunscreens (S): 
(1) PARSOL MC X® at 12.5 ILI/mi. This pale yellow, slightly 
oily , liquid is 2-ethylhexyl 4'-methoxycinnamate. Its molecu-
lar structure and absorpti on spectrum are shown in Fig 1. (2) 
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Figure 1. Molecular structure and absorption spectrum of 2-ethylhexyl 
4'-methoxy-cinnamate in absolute ethanol at 12.5 X 10- 3 J.Ll / ml (product 
concentration x 10 - 3) . Cross-hatched region indica tes UV A absorbance. 
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UL TRA CYD® at 10 mg/ ml. The w hite crystalline powder is 
1, 7, 7-trimeth yl-3-benzylidene-bicyclo-[2.2. 1]-2-heptanone. Its 
molecul ar stru cture and absorption spectrum are shown in Fig 2. 
T wo studies were conducted as indica ted in T able L Ex peri-
mental groups were trea ted concurrentl y within each stud y. It 
should be noted that th e baseline control in th e SSR trea ted g roups 
is SSR plus vehicle. As we have previously shown , in the sa m e 
strain of mouse, an oily vehicle enhan ces SSR tum origenesis [12,17]. 
The mice and methods used are identi cal to those described b y 
Young and associates [12] . Briefl y, g roups o f 40 (20 male, 20 
female) outbred hairless albino mi ce (an in-house strain know n 
as St. John's) were painted w ith the test substance (approx. 150 
ILl over 30 cm2 of fl ank and dorsa l surface, i.e., approximately 5 
ILl/cm 2 skin ; this represents 125 and 250 ng 5-MOP/cm2 with 
preparations of 5-MOP at 25 and 50 ILg/ ml , res pectively) every 
weekd ay for 44-46 w eeks, placed in individual irradiation cages 
and exposed approx. 30 min to 1 h later, to 1.7 J /cm2 of solar 
simulated radiation (290-400 nm ), the UVB (290- 315 nm) com-
ponent o f w hi ch was about 40 mJ /cm 2. D osimetry is described 
by Youn g and associates [1 8]. The dark controls in study 2 w ere 
placed in irradiation cages for about 1 h. 
In general, treatmentlirradiation ran for 44 to 46 weeks, during 
whi ch the mi ce were exa mined once a week fo r skin tum ors, the 
diameters of w hich were measured and the loca tions m apped . In 
study 1, all surviving mice were sacrifi ced at the end of the treat-
mentli rradiati on period . In study 2, half the mice from each 
sex/group exposed to SSR w ere scheduled for sacrifice at the end 
of the treatm entli rradiation period and the remaining half sched-
uled for sacrifi ce after a foll ow-up period of 15 w eeks, during 
which tim e mi ce were examined fo r tum ors every 3-4 w eeks. 
Selection schedule was predetermined at the start o f th e experi-
ment (week 0) and was shown to be independent of bias (see 
Results). 
Thus the total period of the experiments was about 60 w eeks. 
Probability o f survival at between weeks 44-46 w as about 0.7. 
1.2 
1.0 
UJ 0 . 8 
() 
z 
<: 
en 
c: 
o 0.6 
(/) 
en 
<: 
0 . 4 
0 .2 
240 260 280 300 320 340 360 
WAVELENGTH(nm) 
Figure 2. Molecular structure and absorption spectrum of 1,7, 7-tri-
methyl-3-benzylidene-bicyclo 12.2. 1]-2-heptanone in absolute ethanol at 
10 J.Lg/ml (product concentration x 10 - 3) . C ross-hatched region indica tes 
UV A absorbance. 
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Animals were maintained under gold flu o rescent tubes (Thorn , 
U. K .), which do no t emit any ultraviolet radi ation. 
Tumor Histopa'thology At sacrifi ce, tum o rs were fi xed in 
10% formol sa line, All ava ilable tum ors were fi xed, with the 
exception of the 50 ,ug/ ml 5-MOP groups (in w hich onl y a small 
r a nd o m sampl e o f tum o rs was ta ken) and the unirradiated vehicle 
controls o f stud y 2. Standard 8 ,um wax secti ons were prepared 
a nd stained with hematoxy lin and eosin, T wo slides were pre-
p ared fro m each tum o r, each with 6- 8 sectio ns. T his gave two 
s e ts of slides. Each set was coded and examin ed, by one of two 
r esearchers, according to th e followin g criteria. 
1) Carcinoma 
2) Bo rd erline 
i) In vasive 
ii) N oninvasive 
3) Papillo ma 
i) Sessile 
ii) Pedun cul ated 
4) N ot suitable fo r scorin g 
In vasion o f panniculus ca rnosus 
muscl e 
Marked cel lular atypia 
Marked dermal in vasion; pro bably 
ea rl y ca rcin o ma 
Little or no evidence o f derm al 
in vasion 
Cellular appearan ce fa irl y no rmal; 
no evidence o f dermal in vasio n 
Broad based tumo r 
Stalked tumo r (so me tumors showed 
signs o f atypia) 
Vario us reasons; e.g . o bliquely cut 
sections; tum o r very small. 
R es ults were then compared. Disag reement was infrequent but 
in such cases the slides were reexa mined by the in ves tiga tors 
t ogether and a j o int decision taken. In mos t cases, the disagree-
ITlent was due to rea l variation in different preparations, an ex-
p ected consequence of sectionin g different parts o f the tum o r, 
and diagnos is was based on worst case . 
Therea fter , tumor types 1) and 2i) were term ed mali gnant, 
tumor type 2ii) was termed doubtful ly malignant and tum o r types 
3i) and 3ii) were rega rded as benign. 
Statistical Methods Analyses were carried out fo r males, fo r 
fe males, and fo r sexes combined. Pairw ise g ro up comparison and 
t ests for dose-related trend were made as described in the Reslllts, 
sig nificant differences being expressed as jJ < 0.001 , < 0.01, < 
o. OS, o r < 0.1 as appro priate, based on two-tailed tests. Three 
t y pes o f method were used: 
J) An alysis o f time-to-onset of visible tumo rs. 
Only tumors w hich had attained a diameter o f at least 
mm were used in these statistica l analyses . The method of 
Peto et al [1 9] for visible "mortality independent" ) tumors 
was used, based on the o bserved week o f onset of the given 
endpoint. 14 different end-points were used. These were 
time to first tumor o f diameters 1,2,3, 4,5 and 10 mm , tim e 
to 2nd, 3rd , 5th, and 10th tumor o f diameter 1 mm and 
time to 2nd tumor of diameters, 2,3, 4 and 5 mm. Analyses 
were ca rried out for the wh ole stud y period and , in the 
case o f study 2, fo r the trea tmentli rradi ation period onl y. 
II) Analysis of total numbers of tumors seen in-li fe. 
Data were analysed at vario us time points. [n the ea rl y part 
o f the experiment, weeks divisibl e by 5 were chosen, the 
week befo re being chosen if an observation was missing. 
Later on , where observations were less frequent, 5- week 
intervals were used , taking the larges t number o f tumo rs 
seen at any point in the interval. T es ts for signifi cance were 
carried out by rank tests, using the Kruskal- Wallis tes t for 
between-group differences and the method o f Marascuilo 
and McSweeney [20] for dose-related trend. 
III) Analysis of tumo rs seen at death based on histology . 
The method of Peto et al [1 9] fo r " incidental " tum ors was 
used, based on tumors seen in anim als dying in the time 
periods 1-20, 21-41 , 42-49, and 50 + weeks, the third 
interval covering the first set o f terminal kills and the fo urth 
the terminal kills after the follow-u p period . Analyses were 
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based on: presence o f any malignant tumo r; any mali gnant 
or doubtfull y malig nant tumo r; any two mali gnant tumors; 
and an y two mali gnant or doubtfu ll y mali gnant tum ors. 
The mos t intensive an alyses were done w ith the 25 ,ug/ml 5-
MO P gro ups in w hi ch all of the above endpoints were used . In 
the 50 ,ug/ml 5-MOP ± sun screens comparison analyses were 
limited to meth ods I and II as onl y a small sa mple of tum o rs were 
taken fo r histol ogy. In the dark contro l g roups, analyses were 
limited to time of onset o f a v isible tum o r o f diameter 1 m111 or 
greater in the sexes co mbin ed. T um ors were small in size and 
limited in number. 
During the co urse of th e ex perim ents (a bo ut 3 years) ventral 
tum ors were noted in some, but not all , g ro ups o f mice. T hese 
are defin ed as tum o rs w ithin the nip ple lines, in the axill ae o r the 
peri- anal region. The reasons fo r this are not kn own but the St. 
J ohn 's strain appea red to develop a very vari able incidence of such 
tum ors (see Resllits and Discussion). Another strain of hairl ess 
albino mouse (Skhl ) undergoing similar ex periments and kept 
under identi ca l conditi ons did no t develo p spontaneous tum ors . 
It is obviously no t poss ibl e to adj ust the data for spontaneous 
tum o rs on the flank or do rsa l region but ventral tu111 0rs have 
been excluded fro m these analyses because: 
i) Caged-only anim als showed th ese tum o rs. Indeed this group 
had th e second hi ghest incidence w ith 5/40 anim als with a 
first ventral tum o r. 
ii ) The ventral region, as defined above, had neither to pi ca l trea t-
ment nor exposure to SSR. 
iii ) In cidence was sex related (M 80%, F 20%) . 
iv) The variable incidence of th ese tum o rs, among th e di fferent 
groups, with no evid en t pattern , means that the analyses based 
on first tum or are sensiti ve to disto rtio n by spontaneous first 
ventral tumo rs. 
v) These tum ors were almost all benign (see R eslllts). 
RESULTS 
Ventral Tumors All ventral tumo rs fro m all groups were ex-
amined. 26/27 (96%) were benig n and 1/27 (4%) was malignant 
(ca rcinoma). T he carcino ma w as fro m the caged onl y group . 
Dark Controls (Caged Only and Treatment) N one of the 
trea tments, viz. 5-M O P (25 ,ug/ml) with o r w itho ut sun screens 
or vehicle w ithout sun screens, enh anced tum o rigenesis as com-
pared with each oth er and the caged onl y g roups (p > 0.05). AU 
tum o rs were examined hi sto logicall y except those fro m the ve-
hicle w ithout sunscreen g ro up. 29/29 were beni gn. 
SSR Treated Groups T able Il shows tum o r yield data (i. e. 
to tal no. o ftul11 o rs / no . o f survivin g mi ce) fo r the sexes co mbined 
at various tim e points of both studies. T able III gives details by 
g roup and period o f death o f th e number o f anim als (males and 
females combin ed) in stud y 2 for w hich a beni gn, doubtfull y 
malignant o r malignant tum o r was seen histo pathologica ll y. An-
imals with mo re th an one tumo r are counted in the 111 0s t mali g-
nant catego ry. 
COl/lpariso /l oj Vehicle (With out S I/I'lscreens) Croups in S tl/dies 1 
arId 2 . 
T IME T O O N SET A NA L YSIS. In cidences tended to be so mewhat 
higher in study 2 fo r all visib le endpoints. However, no analysis 
showed statistical significa nce at the 95% confid ence level, and 
onl y for 2 of the 14 endpoints (any 2 111m tumo r, any 3 111m 
tum or) was significan ce even at th e 90% confidence level reached. 
It is thus unli kely to be misleadin g to ca rry o ut analyses across 
the two studies. 
TOTA L IN -LI FE TU M OR ANA LYSIS. Up to week 25 in males, but 
not in females or the sexes combined, there was a just signifi ca nt 
(p < 0.05) tendency fo r the numbers of tumo rs to be lo wer in 
stud y 2 than in study 1. Subsequently no di fference was seen in 
either sex . The marginal early difference is unlikely to interfere 
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Table II . M ean M aximum Number of Tumo rs Seen at Various Time Points 
Weeks 19 or 20 
Weeks 24 or 25 
Week s 29 or 30 
Weeks 34 or 35 
Weeks 39 or 40 
Weeks 44 or 45 
Weeks 46-50 
Weeks 51-55 
Weeks 56-60 
S. sunscreens. 
50 J.L~/ 1ll 1 + S 
0. 13 
0.17 
0.31 
0.71 
1. 06 
Study I 
50 J.Lg/ IllI - S Veh.-S 
0.25 0.24 
0.64 0.32 
2.37 0.62 
5.21 0.97 
8.90 1.28 
wi th inte rstudy co mpari sons as 5-M OP trea tm en t has very little 
effect unti l afte r week 25. 
COlllpariso l/ of 5-MOP alld Vehicle C roups Withollt SU I/ screens 
TIME TO ONSET ANALY SIS. A't 50 j.Lg/ml there was clear evi-
dence in both sexes of a pos iti ve effect on tim e to o nset of sin g le 
and multiple tum o rs, parti cu la rl y for multiple sm all tumors w here 
a hi g h level of sig nifi ca nce (p < 0.001) was reached . At 25 j.Lg/ml , 
the in cidence of an y sin g le tum o r of a g iven size was g rea ter but 
not sig nificantly so (p > O. l ) than the vehicle co ntro l but hi ghly 
sig nifi ca nt excesses were often seen in the multiple tumor anal-
yses, e .g. p < 0.001 for 5 o r m ore 1 mm o r larger tumors. 5-
MOP dose-rel ated trend ana lys is, usin g poo led veh icl e d ata from 
studies land 2, was significa nt (p < 0.05) for almost all the 
analyses and hi g hl y sig nifi ca nt (p < 0.001) for m an y, e .g . ten 1 
mm tum o rs and two 2 mm tumors in males, fema les and m ales 
plus fema les. Trend ana lys is fo r 1 mm tumo rs was also done w ith 
these data combined w ith previo us data fo r 5-MO P (in che mical 
fo rm in a simil ar vehicle) a t 100 and 300 j.Lg/ml (see reference 12) 
in w hi ch a vehi cle o nl y contro l was not sig nifi ca ntl y different (p 
> 0. 1) from th ose in s tudies 1 and 2 . A gain , a positive trend fo r 
5-M OP dose was o bserved (p < 0.01). 
TOTAL IN-LI FE TU MOR ANALYS IS. The m ean numbers of tu-
m o rs per survivin g m o use are show n in Tab le II. At 50 j.Lg/ml , 
an excess in tum o rs s tarted to be seen in both sexes around weeks 
35-40 an d was hig hl y sig nifi ca nt (p < 0.001) in the analyses a t 
Sexes Combined 
Study 2 
25 J.Lg/ 1ll1 + S Veh. + S 25 J.Lg/ llll - S Veh. -S 
0.03 0.05 0.03 0.06 
0.J 5 0. 11 0.26 0. 14 
0. 18 0.26 0.44 0.40 
0.39 0.58 1. 33 1.06 
0.81 0.93 5.34 1. 83 
1. 67 1.38 11.41 2.86 
2.79 1.36 15. 36 3.63 
3.29 0.63 15.27 4.46 
4.50 1. 09 11 .78 6.00 
weeks 35 and 40. At 25 j.Lg/ml , there was no diffe rence up to 
week 35. Subseq uentl y, an excess was seen in both sexes w hich 
beca m e hig hl y sig nifi ca nt (p < 0.001) durin g the follow-up period 
between weeks 45-55 . 
TUMO I~ HISTO I'ATHOLO Y AT DEATH. Anal ys is of tumor 
histo patho logy was not d o ne for 5-MOP at 50 j.Lg/m l but at 25 
f.Lg/ mJ there was a nons ig nifica nt in crease in in cidence of malig-
nant o r of malig nant or d o ubtfu ll y m alig nant tum o rs and a sig -
nificant in crease 0) < 0.01) in multipl e tumors of these types. 
COlllparisons of 5-MOP al/d Vehicle CrOllps With SlInscreens 
TIME TO ONSET ANALYS IS. N o ne of th e 14 anal yses for visible 
tumors in individual sexes or sexes co mbined in the treat-
m entlirrad iat io n period or th e tota l peri od showed any signifi cant 
01 > 0. 1) effect o f 5-MOP .(at 25 and 50 j.Lg/ml) w ith sunscreens 
w hen co mpared w ith vehicle w ith sunscreens (from study 2). 
Trend analys is, in the trea tm entlirradiation period , fo r 5-MOP 
dose was no t sig nifIcant for an y of the 14 endpoints in males, 
fe m ales o r bo th at the 95% confidence level. Two analyses showed 
a s ig nifi ca nt trend at the 90% confidence level but as one of these 
was positive (two or more 2 mm tum o rs in males) and the other 
negative (an y 3 mm tum o r in fem ales) th ey may be dismissed as 
chance flu ctuatio n. 
TOTAL IN-LIFE TUMOn ANALYSIS. N o sig nificant differences (p 
> 0.1) were seen between 5- M O P (25 and 50 f.Lg/m)) and control 
(s tud y 2) g ro u ps during the course of th e irradiation. Trend anal-
Table III. Numbers of Mi ce With Tumo rs of Vario us Grades o f Ma lig nancy 
Sexes Co mbined (S tud y 2) 
Type of T umor Period of Death 25 J.Lg/ml + S Veh.+S 25 J.Lg/ ml - S Veh.-S 
Malignant Weeks 1-41 0 0 I 0 
Weeks 42- 49 3 1 13 5 
Weeks 50+ 6 2 6 7 
Total 9 3 20 12 
Doubtfu ll y Weeks 1-4 1 0 0 0 0 
malignant Weeks 42-49 4 2 0 1 
Weeks 50+ 2 2 0 0 
Total (i 4 0 I 
Benign Weeks \-4\ 1 2 3 3 
Weeks".42-49 5 9 3 9 
Weeks 50+ 4 4 3 3 
Total 10 15 9 15 
Nos. of mi ce exa mined mi croscopica ll y/ Nos. of dead mice 
Weeks 1-41 119 
Weeks 42-49 12117 
Weeks 50+ 12/ 14 
Total 25/40 
Animals with morc th an one tumor :lrC cOllllted in the most mali gnan t ca tegory. 
S, sunscreens. 
2/ 10 4/12 3/11 
121\8 \6/17 15/16 
8/ 12 9/11 10/ 13 
22/40 29/40 28/40 
Total 
I 
22 
21 
44 
0 
7 
4 
11 
9 
26 
14 
49 
10/42 
55/68 
39/50 
104/ 160 
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Figure 3_ Actuarial ly a dj~, s tcd Life-Tab le analyses (Kapbn-Meier method) to show protccti ve effcct of add in g sunscreens to anim als treated with 5-
MOP (25 /Lg/ ml) and exposed to ssn .. Notc that the cnd-point is for tumors that have reached a di ameter of at least I mm. 
ysis durin g this pe riod also fa iled to detect an y signifi ca nt differ-
ences. H owever, in both sexes, the mea n number of tumors was 
g r eater in the 25 p,g/ ml g ro up from w eek 45 o nwards (fo ll ow-
up period) altho ug h this did not reach sig nifi ca nce (p < 0.05) 
until at least 5 weeks later. Further analys is showed no di fference 
in tumor size o r frequen cy , during the irradiat io n peri od, between 
a nimals sacrifi ced and those kept for fo ll ow-up. Thus the excess 
of tum o rs in th e 5-MOP g roup ca nn o t be ex plained by any bias 
in the subsets of mi ce chosen for follow-up. 
TUMOR HI STOPATHOLOGY AT DEATH. Ana lys is of the histo-
pathologica l data rest ricted to the treatment/ irradiation period 
s h owed no diffe ren ces signifi cant at the 95% co nfidence level and 
in o nl y o ne (m alig nant or doubtfully m ali gnant tumor in fe m ales) 
was an in crease sig nificant even at the 90% confid ence level seen. 
Analysis based on the tota l stud y pe ri od showed two differen ces 
signifi can t at th e 95% co nfidence level. O ne was for the sa me 
e ndpo int as before; the other was an in crease for multiple o r 
doubtfu ll y mali gnant tum o rs in the sexes combin ed. 
Effect oj SlIlIscreells 011 5-MOP a/ld Vellicle Cro /lps 
T IME TO ONSET ANALYSIS. In bo th sexes o r sexes co mbined, 
the add itio n of sun screens signifi ca ntl y decreased the in cidence of 
tu m o l'S in virtuall y all anal yses, either during th e irradiatio n pe-
riod o r th e irradi ation and fo llow-up period , in th e vehicle and 
5-MOP g roups o r in these g ro ups co mbin ed. In genera l, th e effect 
was m o re m arked w ith the 5-MOP analyses often w ith p < 0.001. 
For exa mpl e, w ith the endpoints fiv e 1 ml11 tumors or one 5 111m 
tumor over the tota l period the sun screens signifi cantly red uced 
tUl110rigenesis in the vehi cle (p < 0.05) and 5-MOP (p < 0.001) 
groups and th ese g roups co mbined (p < 0.001). Fig 3 shows the 
effect of sunscreens o n 5-MOP at 25 p,g / m l. 
TOTAL IN- LI FE TUMOH ANALYSIS. In the 5-MOP gro ups, num-
b e rs of tumors were mark edl y in cre;,sed in th e absence of sun-
screens in both sexes . Signifi ca nce (p < 0.05) star ted to emerge 
at week 25 at 50 p,g/ ml and at 35 at 25 p,g/ ml and became very 
high (p < 0 .001) 5 weeks late r. Numbers of tumors were also 
increased in the vehicle controls in the absence of sun screens but 
to a less m ark ed ex tent. 
TUMO ll l-il STOI'ATHOLOGY AT DEATH. Sta tisti ca l eva luation of 
his to patho logica l data showed that all the analyses for the sexes 
co mbin ed , and m any of those for th e indi vidua l sexes, showed a 
signifi cantl y decreased in cidence of m ali gnant tum o r o r m ali gnant 
or do ubtfull y mali gnant tumor in the vehi cle and 5-MOP g roups 
w ith sun screens. For exa mple, the sunscreens redu ced the in ci-
dence of th e endpoints mali gnant tumor and multiple m alig nant 
o r doubtfull y m alig n:lI1t tumors in the sexes combined over the 
total study period in the ve hicle (p < 0.05) and 5-M OP 0) < 0.01) 
g roups and in these groups combined 0) < 0.001). 
S tlllllllar ), oj Resllits The visible and histo patho logica l data show 
conclu sively that 5-M O P at 25 and 50 p,g/ml without sun screens 
is a ca rcinogen in the presence of SSR and that sun screens inhibit 
photocarci nogenesis w ith and w ith o ut 5-MOP. All the visible 
data analyses show that 5-M OP w ith sunscreens, as compared 
with sun screens alone, does no t enh an ce tu morigenesis or mali g-
nancy durin g the treatment period. However, total in-li fe tumor 
analys is and two of the endpoin ts of the histopatholog ica l data 
over th e total , but not the treatmentlirradiation , period indi ca te 
statisti ca ll y signifi ca nt enh anced risk . 
D ISCUSS IO N 
T he appa rent incidence of spo nraneous benign ventral tum o rs is 
quire hig h but anim als were subj ected to treatment w hi ch must 
inev itabl y be stressful. Furth erm ore, m ale and fema le ani m als, 
althou g h ho used in sepa rate cages, were kept in close proxim ity. 
It has been shown that stress ca n signifi cantl y in crease the inci-
dence of virus induced m ammary tum ors in mi ce [21 J). Gibbs et 
al 122] have shown that ou r st rai n of mouse is ve ry susceptible 
to benign tumors after treatment w ith th e tumor promoter 12-
0-tet radecanoyl-pho rbol-1 3-acetate (TPA) without prior initi a-
tion. It Iud been h ypothes ized that this strain of mouse m ay have 
a hig h in cidence of " inn ate geneti c damage" but subsequent stud-
ies have shown that the sponta neous levels of sister chromatid 
exchange and micronuclei are the sa m e as in the Sk h 1 mouse 
w hich is no t very susceptibl e to tumors induced by TPA alone 
[22]. 
T he inclusion of sunscreens in the vehi cle offered protection 
aga inst SSR photoca rcin ogenesis as has been dem onstrated by 
other work ers [5]. T his is probably due to their absorption of the 
UVB co mponent of SSR . 
As described , the 5-M OP concentration in these preparations 
is obta ined by appropriate dilution of citrus, especiall y berga m ot, 
o ils. Until recently , 5-MOP was the o nly berga mot o il co mpo-
nent that had been reported as having any significant phototox-
icity in m an and in yeast [23,14]. 5,7- D imethoxycoumarin , in the 
presence of UVR, had been reported as an all ergen in hum ans 
[24] and a mutagen in bacteria and m ammalian cells respecti vely 
[25 ]. Its phototumorigeni c sta tus is un known. It has been pre-
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slim ed that 5-MOP is the on ly act ive melan ogenic and photo-
ca rcinogenic compo und in berga m ot o il but this has not been 
verifled. 
It is very appa rent fro m the sta ti stica l analyses of the data that 
th e in cl usion of sun screens in 5-MOP preparations at 25 and 50 
J.Lg/ ml co mpletely eli m in ;j tes th e in creased r isk of tumori genesis 
dur in g th e course of the irradiation period. T he inclusion of sun-
screens also significa ntl y reduces malignancy in the 5-MOP groups. 
There is however some indi ca tion of in creased risk durin g the 
fo llow-up period. Overall , our results appea r to be at so me va r-
iance w ith those of Cartw ri ght and Walter [13] w ho reported that 
5-M O P-co ntainin g sun screens were hi ghl y ca rcinogenic in the 
presence of UVR. H owever, th eir stud y had onl y 6 control mice 
exposed to UVR an d lacked the ap propriate oi ly vehicle plus 
UVR controls which we have conclusively shown to be essenti al 
as an o il y vehicle enhances UVR tumorigenesis [1 2, 17J. 
PARSOL M CX@ and ULTRACYD@ are established UVB 
sun screens. H owever, it is evid ent from Fig 1 that PARSOL 
M CX@ also absorbs signifi ca ntl y in the shorter UV-A region, 
viz. 315-335 nm. UVA absorption of ULTRACYD@ (Fig 2) is 
minimal. It is specul ated th at the abso rpti on of this waveband 
m ay acco un t, at least in part, for our o bserva tion s for it has been 
shown that UV A sun screens can inhi bit 5-M OP phototoxicity 
in the guin ea pig (26]. Recently completed studies in our labo-
ratory ind ica te that the wa veleng th dependen ce for 8-MOP pho-
totumorigeneis [27] is simil ar to tha t of acute effects in w hich the 
320-335 nm waveband has been dem onstrated to be particul ar ly 
poten t (see Yo ung and Magnus [28J and Gasparro [29J for 
references) . 
It has also been shown that cinn am ates, including 2-eth ylhexy l 
4' -methoxycinnamate (viz. PARSOL M CX@), can quench 8-MOP 
and 5-MOP tripl ets in vitro [30J . The sign ificance of this in vivo, 
especially in relation to skin cancer, is not kn own, but th e triplet 
state m ay be important fo r reactions w ith DNA [31] and th e 8-
M.OP tripl et ca n genera te singlet oxygen [32] w hich may have a 
ro le in skin cance r p ro m otion [33]. It has been shown tha t f3-
ca rotene ca n inhibit 8-MOP phototum o rigeneis, possibl y by 8-
M O P trip let or sin glet oxygen quenching [34]. T he fi lters may 
reduce possible UVB initiation. Our experim ental des ign is not 
able to distin gui sh between these possibili ties suggested fo r the 
su nscreens sparin g effect. 
Cons titutively tann ed skin s are less at risk frol11 acute and long-
term hazards of solar radiation [35]. The inclusion of 5-MOp in 
suntan preparations rapidl y achieves the desired cosmetic effect, 
especiall y in skin types I and II who no rmall y do not tan readily 
[36]. T he photoprotecti ve e ffects of a psoralen-indu ced tan has 
been demonstra ted in several studies [35,37 ,38] but there are no 
data ava ilable o n protection frol11 sk in cancer. 
T here is justifiable concern about long.,term hazards, es pecially 
as there is evid ence that PUV A thera py m ay in crease th e in cidence 
o f skin ca nce r in so me pso ri atics [39]. Any estimation of the net 
long-term hazards from the in termi ttent use of sun screens con-
tai nin g psoralens shoul d be viewed against the possible pro tection 
afforded by a tan against further photocarcinogeni c solar radia-
tion . H owever, this calculation is m ade more co mpl ex by indi-
cations that P UV A m ay be more carcinogenic than UVB [40]. 
It is of course difficult to extrapol ate the m o use data described , 
to m an, but it sho uld be no ted th at the mouse model used is 
likely to be exquisitely sensitive for the foll owin g reasons: 
a) The mice received chronic trea tm ent, w ith relatively high vol-
ume/surface area applica tions, fo r up to half their li fe-span. 
U se of5-MOP prepara tions in m an is li ke ly to be intermi ttent, 
i.e., mainly during summ er vacations. 
b) The mice are albin o , so are no t abl e to obtain the poten tia l 
photo protection o ffered by pigm entati on. 
c) Repair of psora len damaged DN A in m ouse and man has not 
been co mpared but, in general , D NA repair o f UVR dam age 
is less good in mouse and other short lived species [41] . 
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d) A m o use epithelial ce ll m ay be 109 tim es m o re likely to g ive 
ri se to a carcino ma than a hum an epithelial cell r 42]. 
T hus, the long- term risk/ benefit ratio remains uncl ea r. 
Durin g the co urse o f trea tm ent non e of the m any quantitati ve 
and qualitative analyses of tu m ors showed a signifi ca ntl y en-
hanced risk by the addition of 5-MOp to sunscreens. D urin g the 
fo llow-up period all but three analyses do not show any sig nif-
icantl y in creased risk w hen 5-MOP is added to sunscreens. Thus, 
although these data ca nnot exclude the poss ibility of increased 
risk of skin cancer in M an, we feel that they do show tha t this 
risk is substantia ll y lower th an has been feared on the basis of 
previous anima l studies wi th 5-M OP wi th and w ithout sunscreens. 
T he controversy of 5-MOP in sun screens cannot be full y re-
solved until po tential long-term benefits ca n be 1110re accurately 
assessed and we would reco mmend furth er studies in this d irec-
ti on, es peciall y in an anim al model fo r hum an pig m entatio n. 
We I"md< Peler Lee fo r I"e slalislien l allal),ses, Rill" T" OIll SO Il fo r excellelll 
leehllien l (/SS ;Slall ce, A lllolI;a Woodcock for 11eI' ass ;slall ce ;t! Ill e II;slolog;e prep-
aralions, Leig" Nelldenoll fo r I" e siSler chrolllal id eXc/lllllge alld lIIierollllelei 
sllIdies, all d )allel A lkillsoll for breedillg mid lIIailllaillillg Ih e large 1IIIIIIbers of 
lII;ce reqllired itl Ihis sllld), . 
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